Amgen, Inc. (AMGN)
337.49
+5.92
(+1.79%)
USD |
NASDAQ |
May 21, 16:00
337.00
-0.49
(-0.15%)
After-Hours: 19:59
Amgen Accounts Payable (Quarterly) : 2.935B for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Biogen, Inc. | 358.50M |
| Gilead Sciences, Inc. | 645.00M |
| Regeneron Pharmaceuticals, Inc. | 1.027B |
| AbbVie, Inc. | 33.61B |
| Moderna, Inc. | 161.00M |